W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > December 2005

FW: DILS06 - Data Integration for the Life Sciences, Cambridge, UK

From: Melissa Cline <cline@pasteur.fr>
Date: Mon, 19 Dec 2005 13:59:02 +0100
To: public-semweb-lifesci@w3.org
Message-Id: <1134997142.25274.11.camel@cumin.sysbio.pasteur.fr>


1st Call for Papers - We apologize for multiple postings

===========================================================
                        DILS 2006

               3rd International Workshop on
           Data Integration for the Life Sciences

           European Bioinformatics Institute, UK
                    20. - 22.7.2006
          http://www.informatik.hu-berlin.de/dils2006
           Proceedings published by Springer LNBI
===========================================================


Important Dates
===============
* Abstract Submission    2. March 2006
* Paper Submission       9. March 2006
* Author Notification   24. April 2006
* Camera-Ready version  16. May 2006


Aims and Scope
==============
Data management and data integration are pertinent problems in the Life
Sciences. Today's advances in molecular biology and molecular medicine are
almost always underpinned by enormous efforts in data management,
automatic data quality assurance, and computational data analysis. Many
existing research directions, such as drug development, systems biology,
or personalized medicine, critically depend on integrating data sets
produced by different experimental methods, in different groups, and at
different levels of granularity. Despite more than a decade of intensive
research in these areas, there remain many unsolved problems in the fields
of data management and data integration. Indeed, these problems are
becoming worse, both due to continuous increases in data volumes and the
growing diversity in types of data that need to be managed. As an example,
integration of data from proteomics mass spectrometry or 2-hybrid assays,
experimental techniques that have only been carried out at a high
throughput scale for the past 2-3 years, are already pressing requirements
in many projects. And the next big challenge is already upon us: The need
to integrate genomics and proteomics data with the vast amounts of medical
data, collected daily in thousands of hospitals world-wide.

DILS 2006 is the third in a workshop series that aims at fostering
discussion, exchange, and innovation in research and development in the
areas of data integration and data management for the Life Science. DILS
2004 in Leipzig and DILS 2005 in San Diego each attracted each around 100
researchers from all over the world. We invite researchers, professionals,
and practitioners to participate and share their knowledge in this forum.
Apart from the presentation of peer-reviewed papers, DILS 2006 will have
two keynote talks, progress reports from important projects in the field,
and a poster session with flash presentations.


Topics of Interest
==================
Papers must address challenges for data integration and data management in
life sciences. A special focus of DILS 2006 lies on papers that address
data management issues at the interface between molecular biology and
medicine. Thus, topics of interest include, but are not limited to:

* Integration of medical and biological data
* Data management and data analysis for personalized medicine
* Management and modelling of phenotype data
* Modelling, storing, and querying biological network data
* Managing complex annotations
* Support for representing and searching biological and medical data types
* Data management for biodiversity
* Knowledge representation and reasoning
* Algorithms and architectures for data integration problems at all levels
* Query processing for biomedical applications
* Data mining and data-driven analysis of Life Science data sets
* Ontology-based data integration and analysis
* Scientific workflows and annotation pipelines
* Laboratory information management systems
* Methods for modelling and assuring data quality
* Integrating bioinformatics and chemoinformatics data
* Data management issues in pharmacogenomics

Note that papers must have a clear focus on biological or biomedical
issues to be considered for acceptance.


Paper Submission
================
DILS 2006 invites two types of papers:

1. Research papers describe novel methods, algorithms, or models for
solving problems relevant to the scope of DILS. The main focus of such
papers must be the advancement of research on data integration or data
management. Research papers must not be longer than 16 pages.

2. Systems or experience papers describe innovative realizations of systems
solving problems relevant to DILS. These papers need not present a new
method, but the systems described must use cutting-edge technology and
must be up-and-running. Papers describing commercial solutions are also
welcome, as long as sufficient detail of the problem and its technical
solution are provided. Systems papers must not be longer than 12 pages.

As for previous DILS conferences, accepted papers will be published by
Springer in the LNCS (Lecture Notes in Computer Science) / LNBI (Lecture
Notes in Bioinformatics) series.

All papers must be previously unpublished and may not be under parallel
review at any other journal, conference, or workshop. Submissions should
be formatted according to LNCS guidelines
(www.springer.de/comp/lncs/authors.html). All submissions will be handled
electronically. Acceptance of each submission will be based by the
expertise of at least three reviewers.

DILS 2006 will also have a poster session. Posters are published on the
DILS web site, but are not part of the proceedings. Selected posters will
have the chance to be presented in a flash presentation session.


Venue
=====
DILS 2006 will take place at the European Bioinformatics Institute (EBI)
in Hinxton, UK (near Cambridge). The EBI is one of the largest centers
world-wide for hosting, managing, and developing data management and data
analysis systems for the Life Sciences. It hosts and contributes to the
maintenance of a number of very important databases in this area, such as
UniProt, Ensembl, InterPro, and the European branch of the International
Nucleotide Sequence Database. Furthermore, the institute is situated
side-by-side with the Wellcome Trust Sanger Institute, one of the biggest
genome research institutes in the world. Together, the EBI and the Sanger
Centre have created an inspiring atmosphere that has turned Cambridge into
of the largest centers for Biotech companies in the United Kingdom.


Organization
============
* Ulf Leser, Humboldt-Universitaet zu Berlin, Germany
* Barbara Eckman, IBM Healthcare & Life Sciences, USA
* Felix Naumann, Humboldt-Universitaet zu Berlin, Germany
* Paul Kersey, European Bioinformatics Institute, Hinxton, UK


Program Committee
=================
Amarnath Gupta, San Diego Supercomputer Center, USA
Anthony Kosky, Axiope Inc, USA
Arek Kasprzyk, European Bioinformatics Institute, UK
Bertram Ludaescher, UC Davis, USA
Bertram Weiss, Schering AG, Germany
Christian Piepenbrock, Epigenomics AG, Germany
David Benton, GlaxoSmithKline, USA
Dennis Paul Wall, Harvard Medical School, USA
Emmanuel Barillot, Institut Curie, Paris, France
Erhard Rahm Universität, Leipzig, Germany
Floris Geerts, University of Edinburgh and Limburgs Universitair Centrum, UK
H V Jagadish, University of Michigan, USA
Hasan Jamil, Wayne State University, USA
Henning Hermjakob, European Bioinformatics Institute, UK
Jacob Koehler, Rothamsted Research, UK
Jamie Cuticchia, Research Triangle Institute, USA
Jignesh Patel, University of Michigan, USA
Joachim Hammer, University of Florida, USA
Juergen Eils, Deutsches Krebsforschungszentrum DKFZ, Germany
Laure Berti-Equille, Universitaire de Beaulieu, France
Limsoon Wong, Institute for Infocomm Research, Singapore
Louiqa Raschid, University of Maryland, USA
Michael Schroeder, Technical University Dresden, Germany
Mike Hogarth, UC Davis, USA
Monica Scannapieco, University of Rome "La Sapienza", Italy
Nick Murall, LION Bioscience, Germany/UK
Norman Paton, University of Manchester, UK
Otto Ritter, AstraZeneca, USA
Paula Matuszek, GlaxoSmithKline Beecham, USA
Peter Bunemann, University of Edinburgh, UK
Peter Karp, SRI International, USA
Peter Mork, Univ. of Washington, Seattle, USA
Sharon Wang, IBM Healthcare and Life Sciences, USA
Stefan Jablonski, Univ. Erlangen-Nuernberg, Germany
Terence Critchlow, Lawrence Livermore National Laboratory, USA
Vipul Kashyap, Partners HealthCare System, USA
Received on Monday, 19 December 2005 12:59:20 GMT

This archive was generated by hypermail 2.3.1 : Tuesday, 26 March 2013 18:00:41 GMT